Merck KGaA is Fined by Brazil for Conspiring to Thwart Generic Drugs

11-08-2014 WSJ Pharmalot BlogComments (0)

GermanyMerck KGaAPharmaceutical

A meeting that took place between Merck KGaA and several other large drug makers in Brazil prompted the country’s anti-trust regulator to fine the German pharmaceutical company $1.8 million for allegedly conspiring to keep distributors from working with generic drug makers.

Read more on WSJ Pharmalot Blog

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top